Do you know the latest trends in Pharmacovigilance in Asia?

 

140billion

Worth of Asia’s Pharmaceutical Market

 

90%

Of 18 – 24-year-olds trust medical information shared on social media

 

More than 100

Approved drugs with labels that contain information on genomic biomarkers

 

$3Billion

Highest fine to date for off-label promotion

 

This lucrative market in Asia remains extremely complicated and fast changing. Make sure you arm yourself with the latest information to stay ahead of your competitors…

Elevating PV Quality and Compliance via Community Collaboration and Digital Health Applications

The 7th Annual Pharmacovigilance Asia Summit once again gathers global and regional regulators together with industry experts to tackle the latest challenges in proactively building and managing a risk-management programme. What are the new quantitative methods in benefit-risk evaluation? How do you create a PV-focused culture and what is the role of the QPPV in Asia? How has digital health initiatives had an impact on the cost and accuracy of PV? How do you leverage on mobile applications to enhance medication adherence and patient support compliance?

We’ll be answering these questions and more as we bring together experts from Europe and APAC!

Download Agenda

Learn from industry leading speakers

View All Speakers

Key Topics in 2016 Include:

icon

The latest PV legislation

how will developments in US and Europe affect Asia?
icon

Leveraging digital health applications

to enhance patient support through detecting and managing safety signals and enhance patient support
 

Pro-actively negotiating risk management plans

and benefit-risk evaluation in Asia – both quantitative and qualitative approaches
icon

Creating a PV-focused culture

and ensuring quality assurance across people, process and technologies
icon

Ensuring continuity and compliance

in M&A environment
icon

How to effectively communicate risk

through education, awareness, and collaboration with the community

Top Reasons to Attend

icon

Covering the breadth of international and regional regulatory bodies – European Medical Agency (EMA), and non ICH countries across Asia Pacific

 

ONLY Asia event unveiling the latest updates from ISoP’s Special Interest Group on Risk Minimisation Methods in Asia

icon

Exclusive: special hands-on mobile application evaluation session where you get to try your hand at the latest digital PV technologies

icon

Derive a holistic understanding from both very technical (beginner) levels and more advanced and strategic points of view

icon

In-depth case studies from leading companies in the region and interactive multi-stakeholder debates

Testimonials

Download Agenda


Sponsors & Exhibitors
Media Partners